Michelle Dalton, ELS

Fellows, residents from around the world show promise for future of retinal research.

Study evaluates the impact of surgical procedure on visual outcomes in patients.

Study results could provide a new preferred treatment paradigm for this population.

Procedure increases lens stability and improves visual acuity in patients.

Investigators looked at trends by geographic variation in practice patterns, perceptions toward opioids, and patient population

Patients underwent short-course, perioperative systemic immunosuppression prior to procedure

Pandemic highlights need for longer-lasting agents to reduce treatment burden in evolving field.

Christopher J. Rapuano, MD, explains how red eye might be something more. Superior limbic keratoconjunctivitis may be identified by lifting the upper lid and having the patient look down.

When exploring novel treatment options for the management of IOP, clinicians should consider a number of independent factors ranging from beneficial behaviors to body position.

Antibiotic resistance against fluoroquinolones is increasing, and that may adversely impact patients with retinal disorders. The introduction of intravitreal injections (IVT) to treat retinal diseases has increased from about 1 million in 2007 to an expected 6 million in 2016 (up from only 4,000 in 2001).

Descemet’s stripping automated endothelial keratoplasty (DSAEK) appears to have a higher risk of postoperative fungal infections (predominantly Candida) when compared to penetrating keratoplasty (PK).

In a study of normal volunteers, once-daily dosing of netarsudil mesylate ophthalmic solution 0.02% lowered IOP relative to baseline by increasing outflow facility and decreasing episcleral venous pressure.

Knowing how to recognize and manage the various forms of conjunctival pigmented lesions can literally mean the difference between life and death in some cases.

A topical treatment that breaks apart disulfide bonds between crystalline lens proteins was shown to increase accommodative amplitude and improve near visual acuity in a randomized, placebo-controlled clinical trial.

In a randomized study, patients receiving bupivocaine had lower pain scores than the control group in the first 30 minutes after surgery. However, other factors may also play a role.

Steven Dell, MD, and Steve Schallhorn, MD, compared the visual and subjective outcomes in patients who wear contact lenses with those who underwent wavefront-guided LASIK for the correction of myopia and astigmatism.

High-level evidence supports the use of anti-vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration (AMD), but falls short of recommending any one agent over another in terms of efficacy or safety, said Paul Sternberg Jr., MD.

Three-year follow-up from the phase I/IIa trial of rAAV.sFlt-1 subretinal injection is encouraging for gene therapy for exudative age-related macular degeneration.

Phase I/II interim data for a bimatoprost sustained-release implant show the device has favorable safety and efficacy and may address the problem of patient nonadherence.

An extended-release therapy that encapsulates travoprost in an intracameral implant showed a statistically significant and clinically meaningful reduction in IOP with results comparable to topical once-daily travoprost ophthalmic solution, said Tom R. Walters, MD, Texan Eye, Austin.

Lines continue to blur as to what constitutes refractive surgery, and likely will continue to blur well into the future. Multiple compounds-phenylephrine and ketorolac 1%/0.3%, (Omidria, Omeros) and the “Dropless” line (Tri-Moxi/Tri-moxi-Vanc, Imprimis Pharmaceuticals)-are designed for use in cataract surgery, but their goal is to improve refractive outcomes. 2015 was the year they started to get some serious attention.

Evidence suggests that nitric oxide can modify both mechanical and vascular events in primary open-angle glaucoma pathogenesis.

Ultra-widefield (UWF) imaging provides clinicians a much broader view of the retinal periphery. The Optos California uses multiple UWF imaging modalities, including color, autofluorescence, fluorescein angiography (FA), and indocyanine green (ICG) angiography in a 200° picture.